ABT is the stock ticker for Abbott Laboratories, a global healthcare company that develops and sells a wide range of health products. Its business is divided into four main segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company's products include generic pharmaceuticals, diagnostic systems, infant and adult nutrition products, and medical devices for cardiovascular and diabetes care, as well as neuromodulation and vascular products.

Enter: NYSE:ABT OCT 31 2025 $135 CALLS Buy in Price: $2.75 - $3.35 Take Profit: $3.69 Stop Bleeding: $2.42 ROI Potential: 34% Exit Within: 132 Minutes

Trading Idea: NYSE:ABT (Abbott Laboratories) - Long Setup 🎯 Idea: LONG ⏰ Timeframe: Daily 📊 Pattern: Bullish Breakout from Consolidation Fundamental Context: Fundamental Score: 5/9 (Neutral). Business: Global Healthcare Leader (Medical Devices, Diagnostics, Nutrition). Growth: Weak Revenue + Strong Net Income Growth YoY. Balance Sheet: Excellent (Debt Score: 10/10). Very strong financial health. Valuation: Fairly Valued on P/E; Overvalued on P/B and P/S. Technical Setup: Trend (D1): Bullish ✅ Catalyst: Recent RSI2 Connors Buy Signal (confirmed oversold bounce). Entry: $135.70 (Break above consolidation resistance). Stop Loss (SL): $130.00 (Below key support and the 50-period SMA). Take Profit (TP): $148.00 (Previous resistance target). Momentum: RSI in bullish territory, MACD showing positive momentum. Risk Management: Risk/Reward (R:R): 1:2.2 Position size based on the risk between entry and stop. Summary: A breakout play on a high-quality healthcare giant with a pristine balance sheet and strong earnings growth, targeting a move to the next resistance level. ⚠️ Disclaimer: Not Financial Advice This analysis is for educational and informational purposes only. It is NOT a recommendation to buy or sell any security. Conduct your own research (DYOR) before making any investment decisions. You are solely responsible for your own trades and investments. Past performance is never indicative of future results. Trading involves significant risk of loss and is not suitable for all investors. #TradingView #ABT #Long #Healthcare #Medical #Dividend #RSI2 #Connors #Breakout #TradingSetup

Hello everyone, This is the last one for today. ABT Abbott Laboratories . What they do? Abbott Laboratories offers pharmaceutical, diagnostic, and nutritional products, as well as medical devices to treat cardiovascular disease and diabetes care products. Operating internationally, the company was founded in 1888 and has its headquarters in Chicago, Illinois. Financial Infos: Market Cap : 236.77 B Revenue : 43.11 B EPS : 7.9964 P/E Ratio : 17.01 Dividend Yield : %1.71 Technical Part: There is a possible break out the Down trend to up and we could expect to continue trend to Up. Volume data is also supports this trend. If it could achive to stay above 134.90 - 135.00 then i would expect to go up and hit 143.50 - 144.00. For other support and resistance levels you can watch the FIB levels that i draw in Chart. Short term i beleive you can make some small gain from ABT. I have already added ABT to my watch list for next week ;) This is just my thinking and it is not invesment suggestion , please do not make any decision with my anaylsis. Have a lovely Weekend to all.

Technical analysis of the company. According to financial indicators, the company is currently undervalued and is supported by SMA200. The target price for the company is $142.

VAH retest long here or another pullback close to POC Good Risk to reward on a solid company

ABT Analysis CMP 134.44 (06-07-2025) Cup & Handle Formation on Bigger tf. Currently Near Resistance Zone. Crossing & Sustaining 135 - 135.20 may lead it towards 150 & then around 180. Should not break 121 now.

Looking for a break above $137 and then a retest before entering. Why: Rounded bottom/saucer Increased volume on green days Shakeout on June 9th Reacting well to previous support and resistance lines

🏥 Abbott Labs (ABT) Trade Alert Positioning in this healthcare giant as it breaks out from consolidation - here's the strategic play: 📌 Trade Levels ▶ Entry: $133.12 (confirmed above SMA 50) 🎯 Target: $147.21 (+10.6%) 🛑 Stop Loss: $126.00 (-5.3% risk) ⚖️ Risk/Reward: 1:2 Why ABT Now? ✅ Fundamental Strength: Net Income Growth: "Strong growth" (+134% YoY in last report) Dividend Aristocrat: 50+ years of dividend growth (current yield 1.9%) Debt Health: Score 10/10 (Debt/Equity 0.26, Interest Coverage 15x) ✅ Technical Triggers: Bullish crossover (50D > 200D MA) RSI 55 - neutral with room to run Volume surge on $132 breakout Measured move target aligns with $147 zone 📊 Trade Management: Entry: $133.12 (market price) Scale In: Add at $130 if tested Adjust Stop: Move to breakeven at $136 Partial Profit: Take 50% at $140 ⚠️ Key Risks: Sector rotation out of healthcare FDA delays on new devices Strong resistance at $138 (prior highs) ABT dominates 4 growth segments: Medical Devices (44% revenue) Diagnostics (32%) Nutrition (12%) Generics (12%) Recent FDA approval for Freestyle Libre 3 drives upside. Trade active until next earnings (Oct 18). Let me know your take! 👇 #HealthcareStocks #DividendInvesting #BreakoutTrade

Looks like #ABT might be on its way to a cup and handle, any thoughts here? www.tradingview.com